Status:
COMPLETED
Stop Addiction Stigma
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial evaluates the impact of a Stop Addiction Stigma (SAS) training workshop with a short description of the conditions related to addiction (vignettes) on stigmatizing attitudes toward...
Detailed Description
PRIMARY OBJECTIVE: I. To describe the impact of SAS training on participants' responses to people with a substance impairment. SECONDARY OBJECTIVES: I. To evaluate the feasibility of stigma trainin...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Employee of Ohio State University Wexner Medical Center (OSUWMC)
- Age ≥ 18 years
- Participants must be able to read and comprehend survey items
Exclusion
Key Trial Info
Start Date :
October 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT06582030
Start Date
October 17 2023
End Date
December 31 2023
Last Update
September 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210